Baptist Health has installed the AccuBoost system for use in radiation treatment following breast cancer surgery.

ImaginAb and Dainippon Seiki have reached a technology agreement pertaining to the development of automated chemistry systems for fluorination of proteins and peptides for diagnostic imaging with PET.

New recommendations from the American Thyroid Association on outpatient radioiodine (131I) treatment to minimize unintended radiation exposure and maximize the safety of patients, their families and the public have been published in the April issue of Thyroid.

The number of uninsured hospital stays grew by 21 percent between 2003 and 2008, according to an April report from the Agency for Healthcare Research and Quality (AHRQ) under the Healthcare Cost and Utilization Project (HCUP).

Women diagnosed with false-positive screening mammography results report negative psychological impacts for up to one year after the diagnosis, according to a study published in the April issue of British Journal of Surgery, leading the authors to call for breast imaging stakeholders to revise the information they share with women to mention these possible negative psychological effects.

Hendricks Holdings has invested in NorthStar Medical Radioisotopes, which will allow the company to introduce new technologies and production methodologies for molybdenum-99 and other radioisotopes.

The Rhode Island Senate has approved legislation to establish a state health benefit exchange.

The breast cancer screening recommendations updated by the U.S. Preventative Services Task Force (USPSTF) in November 2009 have confused many women, suggesting a need for educational materials directed to consumers, a study published in the May issue of American Journal of Preventive Medicine reported.